Screener
Vir Biotechnology, Inc. VIR Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s gross margin?
- Vir Biotechnology, Inc. (VIR) reported gross margin of 96.1% in Q2 2025.
- How has Vir Biotechnology, Inc.'s gross margin changed year-over-year?
- Vir Biotechnology, Inc.'s gross margin decreased by 2.8% year-over-year, from 98.8% to 96.1%.
- What is the long-term trend for Vir Biotechnology, Inc.'s gross margin?
- Over 4 years (2020 to 2024), Vir Biotechnology, Inc.'s gross margin has grown at a -0.3% compound annual growth rate (CAGR), from 100% to 98.9%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Vir Biotechnology, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude